Cellular metabolism via provision of exogenous triglycerides and essential fatty acids

"Cellular metabolism via provision of exogenous triglycerides and essential fatty acids" is not a specific molecular target but rather describes a physiological process. This process involves the absorption, transport, storage, and utilization of dietary triglycerides and essential fatty acids by cells throughout the body. Triglycerides are broken down in the intestine into monoglycerides and free fatty acids before being absorbed; they are then reassembled into triglycerides within enterocytes for transport in chylomicrons through the lymphatic system to peripheral tissues[3][6]. Essential fatty acids—such as linoleic acid (omega‑6) and alpha-linolenic acid (omega‑3)—cannot be synthesized de novo by humans; they must be obtained from the diet[6]. Once delivered to tissues via lipoproteins like chylomicrons or VLDL particles, these lipids serve as major energy sources through β‑oxidation or are incorporated into cell membranes. The regulation of this metabolic pathway is complex—controlled by hormonal signals such as insulin (which promotes lipid storage) or glucagon/adrenaline (which promote lipolysis)[1][2]. Dysregulation can contribute to diseases including obesity, diabetes mellitus type 2, cardiovascular disease due to altered lipid profiles or deficiencies in essential fats leading to skin/hair changes or impaired growth[1][2][6]. This entry does *not* correspond to a discrete therapeutic target such as an enzyme ("lipoprotein lipase"), transporter ("fatty acid transport protein"), receptor ("GPR120"), etc., but rather refers broadly to cellular processes dependent on nutrient supply. For structured data purposes it should be flagged as incorrect/not a valid molecular target per your conventions.

Other names

Exogenous triglyceride and essential fatty acid provisionDietary triglyceride and essential fatty acid supplementationTriglyceride and essential fatty acid delivery